For the Inventor, By the Inventor

Enter inventor name

Sterling, MA, United States of America

Mark G Currie

USPTO Granted Patents = 70 (Patent Applications = 53)

CIPO Patents = 8 (Patent Applications = 14)

EPO Patents = 16 (Patent Applications = 24)

Average Co-Inventor Count = 3.9

ph-index = 15

Forward Citations = 728(Granted Patents)

Forward Citations (Not Self Cited) = 529(Dec 10, 2025)

Inventors with similar research interests:

Location History:

St. Charles, MO (US) (1992 - 2003)
Marlborough, MA (US) (2005)
Sterling, MA (US) (2002 - 2021)
Boston, MA (US) (2016 - 2022)

Company Filing History:

Ironwood Pharmaceuticals, Inc.

11 out of 1,323

G.d. Searle & Company

4. 10 out of 130

Sunovion Pharmaceuticals Inc.

Cyclerion Therapeutics, Inc.

7. 1 out of 3,288

Monsanto Company

8. 1 out of 200

Pharmacia Corporation

Ironwood Pharmaceutical, Inc.

10. 1 out of 832,843

Other

patents

Years Active: 1992-2022

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

sGC Stimulators

CNS Disorders

Gastrointestinal Disorders

Indole Compounds

Heart Failure Treatments

Bile Acid Sequestrants

Asthma Treatments

Glucocorticoids

Fatty Acid Modifications

CRTH2 Modulators

Colon Cleansing

Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

70 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11357777 - Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH) (2022-06-14),

2. 11207323 - sGC stimulators (2021-12-28),

3. 10702486 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2020-07-07),

4. 10639308 - sGC stimulators (2020-05-05),

5. 10618938 - Compositions for colon cleansing and the treatment of gastrointestinal disorders (2020-04-14),

6. 10517874 - sGC stimulators (2019-12-31),

7. 10328036 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2019-06-25),

8. 10183021 - sGC stimulators (2019-01-22),

9. 9907764 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2018-03-06),

10. 9840536 - Methods and compositions for the treatment of gastrointestinal disorders (2017-12-12),

11. 9650417 - Treatments for gastrointestinal disorders (2017-05-16),

12. 9617305 - Treatments for gastrointestinal disorders (2017-04-11),

13. 9586937 - sGC stimulators (2017-03-07),

14. 9527887 - Treatments for gastrointestinal disorders (2016-12-27),

15. 9498452 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2016-11-22),

Title: Mark G Currie - Pioneering Inventor from Sterling, MA

Introduction: Mark G Currie is a distinguished inventor hailing from Sterling, MA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Mark G Currie holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing novel solutions.

Career Highlights: Throughout his illustrious career, Mark G Currie has been recognized for his exceptional problem-solving skills and forward-thinking approach, leading to the development of cutting-edge inventions that have made a significant impact on society.

Collaborations: Mark G Currie has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion: Mark G Currie's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, inspiring future generations to push the boundaries of what is possible through inventive thinking and creativity.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…